Cleared Special

K162426 - nva

K162426 is the FDA 510(k) clearance for nva by Nvision Biomedical Technologies, LLC. It is a Class 2 Orthopedic device (product code MAX) cleared through the Special 510(k) pathway after a 30-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2016
Decision
30d
Days
Class 2
Risk

K162426 is an FDA 510(k) clearance for the nva, nvp, and nvt. Classified as Intervertebral Fusion Device With Bone Graft, Lumbar within the MAX classification (a category for intervertebral fusion devices and spinal implants), Class II - Special Controls.

Submitted by Nvision Biomedical Technologies, LLC (San Antonio, US). The FDA issued a Cleared decision on September 29, 2016 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3080 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Nvision Biomedical Technologies, LLC devices

Submission Details

510(k) Number K162426 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 30, 2016
Decision Date September 29, 2016
Days to Decision 30 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
92d faster than avg
Panel avg: 122d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3080
Definition Intended To Stabilize Spinal Segment To Promote Fusion In Order To Restrict Motion And Decrease Pain Using Bone Graft.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MAX Intervertebral Fusion Device With Bone Graft, Lumbar

All 596
Devices cleared under the same product code (MAX) and FDA review panel - the closest regulatory comparables to K162426.
T-PAL Spacer System, T-PAL Titanium Spacer System, SYNFIX Evolution System
K162358 · Synthes USA Products, LLC · Nov 2016
SeaSpine Spacer System- Hollywood NanoMetalene, Hollywood VI NanoMetalene, Ventura NanoMetalene
K162715 · SeaSpine Orthopedics Corporation · Oct 2016
Rampart D Lumbar Interbody Fusion Device
K160074 · Spineology, Inc. · Oct 2016
Cascadia Interbody System
K162264 · K2m, Inc. · Sep 2016
JULIET® LL Lateral Lumbar Cage
K161888 · Spineart · Sep 2016
NuVasive Lumbar Interbody Implants
K161230 · Nu Vasive, Incorporated · Aug 2016